14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $228.74 0 %
High/ Low $228.74 - $228.74 0%
Chg 7 Days N/A $228.74 $228.74
Chg 30 Days N/A $228.74 $228.74
Chg 12 mos 15.73 % $197.65 $228.74
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 19.62 % Width: 8.49 %
Pred. range - 3 mos $228.74 - $228.74 0 % - 0 %
Pred. range - 12 mos $262.86 - $285.19 14.92 % - 24.68 %
Short MA avg 3 mos Sell Dec 19, 2023 - 57 days
Long MA avg 3 mos Sell Jan 31, 2024 - 29 days
Short/Long MA avg 3 mos Sell Jan 31, 2024 - 29 days
Short MA avg 12 mos Sell Jan 10, 2024 - 43 days
Long MA avg 12 mos Buy Aug 23, 2023 - 139 days
Short/Long MA avg 12 mos Buy Aug 31, 2023 - 133 days
Pivot Short Sell Mar 11, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Seattle Genetics

Seattle Genetics Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibit... SGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT